U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07012395) titled 'A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis' on May 27.
Brief Summary: This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) maintenance treatment.
Study Start Date: May 27
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis
Inflammatory Bowel Diseases
Colitis
Colitis, Ulcerative
Intervention:
DRUG: SPY001
Experimental
Recr...